The central nervous disorders therapeutics market was valued at $117.55 million in 2020, and is projected to reach $232.29 million by 2030, registering a CAGR of 7.3% from 2021 to 2030.
The central nervous disorders therapeutics market was valued at $117.55 million in 2020, and is projected to reach $232.29 million by 2030, registering a CAGR of 7.3% from 2021 to 2030.